{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:46:40Z","timestamp":1785757600991,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.msard.2026.107073","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:08:03Z","timestamp":1770883683000},"page":"107073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prevalence and factors associated with polypharmacy among people with multiple sclerosis (PwMS) receiving outpatient rehabilitation: A cross-sectional study"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2876-2248","authenticated-orcid":false,"given":"Gregory","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Scandiffio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2026.107073_bib0001","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12883-024-03815-9","article-title":"Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study","volume":"24","author":"Abbasi Kasbi","year":"2024","journal-title":"BMC. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107073_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.24095\/hpcdp.37.2.02","article-title":"Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts","volume":"37","author":"Amankwah","year":"2017","journal-title":"Health Promot. Chronic. Dis. Prev. Can."},{"issue":"7","key":"10.1016\/j.msard.2026.107073_bib0003","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American geriatrics society 2023 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.msard.2026.107073_bib0004","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/pharmaceutics14030592","article-title":"Prevalence and severity of potential drug\u2013drug interactions in patients with multiple sclerosis with and without polypharmacy","volume":"14","author":"Bachmann","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.msard.2026.107073_bib0005","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1177\/1352458519856847","article-title":"Beyond rehabilitation: a prevention model of reserve and brain maintenance in multiple sclerosis","volume":"25","author":"Brandstadter","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107073_bib0006","unstructured":"Canadian Society for Exercise Physiology (CSEP). Canadian physical activity guidelines for adults with multiple sclerosis. Accessed August 5, 2025. https:\/\/csepguidelines.ca\/guidelines\/multiple-sclerosis\/."},{"issue":"9","key":"10.1016\/j.msard.2026.107073_bib0007","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11910-023-01289-9","article-title":"Polypharmacy in multiple sclerosis: prevalence, risks, and mitigation strategies","volume":"23","author":"Chapman","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.msard.2026.107073_bib0008","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/13524585221122207","article-title":"Polypharmacy and multiple sclerosis: a population-based study","volume":"29","author":"Chertcoff","year":"2023","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2026.107073_bib0009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11910-019-1002-3","article-title":"Exercise as medicine in multiple sclerosis\u2014time for a paradigm shift: preventive, symptomatic, and disease-modifying aspects and perspectives","volume":"19","author":"Dalgas","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.msard.2026.107073_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221108391","article-title":"Associated factors of potential drug-drug interactions and drug\u2013food interactions in patients with multiple sclerosis","volume":"13","author":"Debus","year":"2022","journal-title":"Ther. Adv. Chronic. Dis."},{"issue":"8","key":"10.1016\/j.msard.2026.107073_bib0011","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaneurol.2018.0611","article-title":"Use of vitamins and dietary supplements by patients with multiple sclerosis: a review","volume":"75","author":"Evans","year":"2018","journal-title":"JAMa Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107073_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211120","article-title":"Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: a single-center study. Infante-Duarte C","volume":"14","author":"Frahm","year":"2019","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2026.107073_bib0013","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1038\/s41598-019-40283-5","article-title":"Multi-drug use among patients with multiple sclerosis: a cross-sectional study of associations to clinicodemographic factors","volume":"9","author":"Frahm","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.msard.2026.107073_bib0014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13293-019-0243-9","article-title":"Polypharmacy in patients with multiple sclerosis: a gender-specific analysis","volume":"10","author":"Frahm","year":"2019","journal-title":"Biol. Sex. Differ."},{"issue":"2","key":"10.1016\/j.msard.2026.107073_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14740338.2020.1720646","article-title":"Polypharmacy among patients with multiple sclerosis: a qualitative systematic review","volume":"19","author":"Frahm","year":"2020","journal-title":"Expert. Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.msard.2026.107073_bib0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.therap.2019.10.001","article-title":"A general review of definitions, descriptions and determinants","volume":"75","author":"Guillot","year":"2020","journal-title":"Therapies"},{"key":"10.1016\/j.msard.2026.107073_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105214","article-title":"Increased odds of alcohol consumption, cannabis, and illicit substances use in cigarette smoking multiple sclerosis patients","volume":"80","author":"Hamidi","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2026.107073_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016149","article-title":"Smoking and multiple sclerosis: an updated meta-analysis","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107073_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.946351","article-title":"Screening for severe drug-drug interactions in patients with multiple sclerosis: a comparison of three drug interaction databases","volume":"13","author":"Hecker","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.msard.2026.107073_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030178","article-title":"Association of cannabis use with cardiovascular outcomes among US Adults","volume":"13","author":"Jeffers","year":"2024","journal-title":"JAHA"},{"key":"10.1016\/j.msard.2026.107073_bib0021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.copsyc.2020.07.005","article-title":"The short-term and long-term effects of cannabis on cognition: recent advances in the field","volume":"38","author":"Kroon","year":"2021","journal-title":"Curr. Opin. Psychol."},{"issue":"11","key":"10.1016\/j.msard.2026.107073_bib0022","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2026.107073_bib0023","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.apmr.2013.05.015","article-title":"Development of Evidence-Informed Physical Activity Guidelines for Adults With Multiple Sclerosis","volume":"94","author":"Latimer-Cheung","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"6","key":"10.1016\/j.msard.2026.107073_bib0024","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107073_bib0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2026.107073_bib0027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000368191","article-title":"Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005-2013","volume":"61","author":"Nishtala","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.msard.2026.107073_bib0028","doi-asserted-by":"crossref","DOI":"10.7322\/abcshs.2020137.1899","article-title":"Association of clinical epidemiological factors to polypharmacy among patients with multiple sclerosis: real-life data","volume":"46","author":"Oliveira","year":"2021","journal-title":"ABCS Health Sci."},{"issue":"10","key":"10.1016\/j.msard.2026.107073_bib0029","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/JOM.0b013e3181b8c155","article-title":"Association of Comorbid Mental Health Symptoms and Physical Health Conditions With Employee Productivity","volume":"51","author":"Parker","year":"2009","journal-title":"J. Occup. Environ. Med."},{"issue":"21","key":"10.1016\/j.msard.2026.107073_bib0030","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1212\/WNL.0000000000000446","article-title":"Effects of cannabis on cognition in patients with MS: a psychometric and MRI study","volume":"82","author":"Pavisian","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2026.107073_bib0031","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2125.2012.04350.x","article-title":"Herb\u2013drug interactions: an overview of systematic reviews","volume":"75","author":"Posadzki","year":"2013","journal-title":"Brit J. Clin. Pharma."},{"key":"10.1016\/j.msard.2026.107073_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102009","article-title":"Cannabis use in people with multiple sclerosis and spasticity: a cross-sectional analysis","volume":"41","author":"Rice","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107073_bib0033","series-title":"Atlas of MS 3rd Edition","year":"2020"},{"issue":"3","key":"10.1016\/j.msard.2026.107073_bib0034","first-page":"239","article-title":"Polypharmacy in multiple sclerosis: current knowledge and future directions","volume":"118","author":"Thelen","year":"2021","journal-title":"Mo Med."},{"issue":"5","key":"10.1016\/j.msard.2026.107073_bib0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jpsychores.2014.02.013","article-title":"Polypharmacy in multiple sclerosis: relationship with fatigue, perceived cognition, and objective cognitive performance","volume":"76","author":"Thelen","year":"2014","journal-title":"J. Psychosom. Res."},{"issue":"11","key":"10.1016\/j.msard.2026.107073_bib0036","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1742-1241.2012.03008.x","article-title":"Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review: evidence evaluation of drugs with herbs and dietary supplements","volume":"66","author":"Tsai","year":"2012","journal-title":"Int. J. Clin. Pr."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:05:22Z","timestamp":1785755122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826001094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"alternative-id":["S2211034826001094"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107073","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and factors associated with polypharmacy among people with multiple sclerosis (PwMS) receiving outpatient rehabilitation: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107073"}}